Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M112,127Revenue (TTM) $M37,533Net Margin (%)3.3Altman Z-Score1.3
Enterprise Value $M132,264EPS (TTM) $0.5Operating Margin %9.3Piotroski F-Score5
P/E(ttm)83.8Beneish M-Score-2.7Pre-tax Margin (%)7.0Higher ROA y-yN
Price/Book76.210-y EBITDA Growth Rate %-1.9Quick Ratio0.6Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %-8.7Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow18.8y-y EBITDA Growth Rate %-65.9ROA % (ttm)1.6Higher Current Ratio y-yN
Dividend Yield %4.8PEG--ROE % (ttm)46.7Less Shares Outstanding y-yN
Payout Ratio %417Shares Outstanding M2,684ROIC % (ttm)8.7Gross Margin Increase y-yY

Gurus Latest Trades with GSK

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GSK is held by these investors:



GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2288.73view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1496.4view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29684.88view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12246view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14196.57view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12246view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    Pernix: An Investor's Rationale to Staying Long Mar 23 2017 
    Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter Mar 22 2017 
    Gilead Sciences Raises Dividend by Double Digits Feb 22 2017 
    If You Want Yield, Look to the UK Feb 19 2017 
    Flood of News Presents Buying Opportunity Jan 17 2017 
    Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
    GlaxoSmithKline, Vodafone Hit 3-Year Low Prices Dec 24 2016 
    Asset Sales, New Projects Fuel 6.7% Yield Dec 07 2016 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    Jeff Auxier Curbs Multiple Positions in 3rd Quarter Dec 01 2016 

    More From Other Websites
    GlaxoSmithKline’s 1Q17 Estimates: Pharmaceuticals Segment Apr 25 2017
    GlaxoSmithKline’s 1Q17 Estimates: Revenues Expected to Grow Apr 25 2017
    GlaxoSmithKline’s 1Q17 Earnings: Analysts’ Estimates Apr 25 2017
    Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More Apr 25 2017
    First malaria vaccine to be tested in Africa, with boost from Lexington's Agenus Apr 24 2017
    3 Dividend Stocks That Retirees Should Avoid Apr 22 2017
    Barclays -- Mired In Mud (Again) -- Should Dump Its CEO Apr 21 2017
    Analyst Estimates for Novartis’s 1Q17 Earnings Apr 21 2017
    What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings? Apr 21 2017
    4 Stocks Are Showing Red Flags -- Here's When to Sell Apr 21 2017
    $3M award in suit against drug company over man's suicide Apr 20 2017
    Teva's new asthma inhaler poses first competition for GSK's Advair Apr 20 2017
    Here's Why Innoviva Inc. Lost 10% Today Apr 20 2017
    GSK must pay $3 million in generic Paxil suicide lawsuit: U.S. jury Apr 20 2017
    As Price Falls, Vetr Upgrades GlaxoSmithKline To Buy Apr 20 2017
    Innoviva director vote drama hands last-minute loss to Sarissa Apr 20 2017
    ZappRX gets $25 million from Qiming US to expand into the U.S. drug prescription market Apr 19 2017
    Activist Sarissa says Innoviva backed out of proxy settlement deal Apr 19 2017
    There Have Been Few Losers Since The Brexit Vote, But It's About To Get Ugly Apr 18 2017
    [$$] Science looks to nucleic acids to create right genetic vaccine recipe Apr 18 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)